Press release

Siemens Healthineers Digitalizes Healthcare with New Molecular Imaging Innovations at EANM 2019

EANM 2019 in Barcelona, Spain: Booth 58

Published on October 11, 2019

1

Not yet commercially available in the European Union nor available for sale in the U.S. or any other country. Future availability cannot be guaranteed.

2

xSPECT Quant 131 is not yet commercially available in the U.S. or some other countries. Future availability cannot be guaranteed.

Siemens Healthineers 2018

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.